NAD metabolism and the SLC34 family: evidence for a liver-kidney axis regulating inorganic phosphate

書誌事項

公開日
2018-09-14
資源種別
journal article
権利情報
  • http://www.springer.com/tdm
DOI
  • 10.1007/s00424-018-2204-2
公開者
Springer Science and Business Media LLC

この論文をさがす

説明

The solute carrier 34 (SLC34) family of membrane transporters is a major contributor to Pi homeostasis. Many factors are involved in regulating the SLC34 family. The roles of the bone mineral metabolism factors parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23) in Pi homeostasis are well studied. Intracellular Pi is thought to be involved in energy metabolism, such as ATP production. Under certain conditions of altered energy metabolism, plasma Pi concentrations are affected by the regulation of a Pi shift into cells or release from the tissues. We recently investigated the mechanism of hepatectomy-related hypophosphatemia, which is thought to involve an unknown phosphaturic factor. Hepatectomy-related hypophosphatemia is due to impaired nicotinamide adenine dinucleotide (NAD) metabolism through its effects on the SLC34 family in the liver-kidney axis. The oxidized form of NAD, NAD

収録刊行物

被引用文献 (2)*注記

もっと見る

参考文献 (120)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ